Trials (The Maastricht UMC+ Comprehensive Cancer Center): Revision history

15 December 2025

• curprev 17:0717:07, 15 December 2025‎ Francine talk contribs‎ 51,333 bytes +218‎ No edit summary undo

6 December 2025

• curprev 12:4212:42, 6 December 2025‎ Lucas talk contribs‎ m 51,115 bytes +1,701‎ Update categories. undo

4 December 2025

• curprev 17:2917:29, 4 December 2025‎ Larysse talk contribs‎ 49,414 bytes +56‎ No edit summary undo

2 December 2025

• curprev 14:0114:01, 2 December 2025‎ Lucas talk contribs‎ m 49,358 bytes +90‎ Update categories. undo

5 December 2023

• curprev 18:1718:17, 5 December 2023‎ Francine talk contribs‎ 49,268 bytes +49,268‎ Created page with "{{forpatients}} {{forresearchers}} {{forproviders}} Go back to The Maastricht UMC+ Comprehensive Cancer Center page '''NCTID''': NCT02968303 '''Title''': Induction Therapy With Vemurafenib and Cobimetinib to Optimize Nivolumab and Ipilimumab Therapy '''Study Summary''': Rationale: The combination of ipilimumab and nivolumab induces relatively high response rates and promising response depth in late stage melanoma. Nevertheless, it takes time till responses occu..."